Daniel-Fischer, L; Antlanger, M; Cejka, D; Eller, K; Gauckler, P; Odler, B; Rudnicki, M; Säemann, MD; Schmidt, A; Sunder-Plassmann, G; Wiesholzer, M; Windpessl, M; Zitt, E; Koenig, F; Greenbaum, LA; Kronbichler, A; Aufricht, C.
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design.
Kidney Int Rep. 2024; 9(2):478-481
Doi: 10.1016/j.ekir.2023.10.027
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG